# The Pharmacokinetics of Dolutegravir, Darunavir/Cobocistat When Co-administered in Healthy Volunteers

> **NCT03094507** · PHASE1 · COMPLETED · sponsor: **St Stephens Aids Trust** · enrollment: 21 (actual)

## Conditions studied

- HIV

## Interventions

- **DRUG:** Tivicay
- **DRUG:** Rezolsta

## Key facts

- **NCT ID:** NCT03094507
- **Lead sponsor:** St Stephens Aids Trust
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-04-19
- **Primary completion:** 2018-01-17
- **Final completion:** 2018-03-17
- **Target enrollment:** 21 (ACTUAL)
- **Last updated:** 2018-05-22

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03094507

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03094507, "The Pharmacokinetics of Dolutegravir, Darunavir/Cobocistat When Co-administered in Healthy Volunteers". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03094507. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*